EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

A simple method for assessing intestinal inflammation in Crohn's disease



A simple method for assessing intestinal inflammation in Crohn's disease



Gut 47(4): 506-513



Background and aims: Assessing the presence and degree of intestinal inflammation objectively, simply, and reliably is a significant problem in gastroenterology. We assessed faecal excretion of calprotectin, a stable neutrophil specific marker, as an index of intestinal inflammation and its potential use as a screening test to discriminate between patients with Crohn's disease and those with irritable bowel syndrome. Methods: The validity of faecal calprotectin as a marker of intestinal inflammation was assessed in 22 patients with Crohn's disease (35 studies) by comparing faecal excretions and concentrations using four day faecal excretion of 111indium white cells. A cross sectional study assessed the sensitivity of faecal calprotectin concentration for the detection of established Crohn's disease (n=116). A prospective study assessed the value of faecal calprotectin in discriminating between patients with Crohn's disease and irritable bowel syndrome in 220 patients referred to a gastroenterology clinic. Results: Four day faecal excretion of 111indium (median 8.7%; 95% confidence interval (CI) 7-17%; normal <1.0%) correlated significantly (p<0.0001) with daily (median ranged from 39 to 47 mg; normal <3 mg; r=0.76-0.82) and four day faecal calprotectin excretion (median 101 mg; 95% CI 45-168 mg; normal <11 mg; r=0.80) and single stool calprotectin concentrations (median 118 mg/l; 95% CI 36-175 mg/l; normal <10 mg/l; r=0.70) in patients with Crohn's disease. The cross sectional study showed a sensitivity of 96% for calprotectin in discriminating between normal subjects (2 mg/l; 95% CI 2-3 mg/l) and those with Crohn's disease (91 mg/l; 95% CI 59-105 mg/l). With a cut off point of 30 mg/l faecal calprotectin has 100% sensitivity and 97% specificity in discriminating between active Crohn's disease and irritable bowel syndrome. Conclusion: The calprotectin method may be a useful adjuvant for discriminating between patients with Crohn's disease and irritable bowel syndrome.

(PDF emailed within 0-6 h: $19.90)

Accession: 010098143

Download citation: RISBibTeXText

PMID: 10986210

DOI: 10.1136/gut.47.4.506



Related references

Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease?. Gut 30(9): 1236-1240, 1989

Faecal calprotectin A simple sensitive quantitative method for assessing intestinal inflammation in man. Gastroenterology 112(4 SUPPL ): A1103, 1997

Linoleic acid specifically and markedly increases interleukin-8 secretion by human intestinal smooth muscle cells isolated from Crohn's bowel: Evidence that modification of dietary fat may attenuate intestinal inflammation in Crohn's disease. Gastroenterology. 122(4 Suppl. 1): A-146, Il, 2002

Role of inflammasomes in intestinal inflammation and Crohn's disease. Inflammatory Bowel Diseases 21(1): 173-181, 2015

Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflammatory Bowel Diseases 12(12): 1101-1106, 2006

Cytokine networks in the development of intestinal inflammation in Crohn's disease. Folia Pharmacologica Japonica 120(1): 39-45, July, 2002

Subclinical intestinal inflammation in siblings of children with Crohn's disease. Digestive Diseases and Sciences 55(12): 3502-3507, 2011

Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn's disease. Alimentary Pharmacology & Therapeutics 37(5): 537-545, 2013

Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn's Disease?. Journal of Pediatric Gastroenterology and Nutrition (): -, 2016

Subclinical intestinal inflammation: an inherited abnormality in Crohn's disease relatives?. Gastroenterology 124(7): 1728-1737, 2003

Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease. Journal of Pediatric Gastroenterology and Nutrition 54(2): 298-305, 2012

The critical role of LIGHT in promoting intestinal inflammation and Crohn's disease. Journal of Immunology 174(12): 8173-8182, 2005

The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease. Gastroenterology 101(1): 84-89, 1991

Plasma postheparin diamine oxidase activity. Development of a simple technique of assessing Crohn's disease. Diseases of the Colon and Rectum 31(7): 529-532, 1988

Tumour necrosis factor inhibition by oxpentifylline and intestinal inflammation in Crohn's disease. Lancet 345(8962): 1445-1445, 1995